Compare
Abbott Laboratories vs Baxter International (ABT vs BAX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Baxter International (BAX) +43.7%; so far this year the figures are -12.3% and +35.0%.
Abbott Laboratories is the larger company by market value, about 14.3 times the size of Baxter International.
Revenue grew +10.0% at ABT and +5.3% at BAX over the last year.
ABT yields 2.29%. BAX yields 0.16%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | BAX | |
|---|---|---|
| Price | $109.93 | $25.79 |
| 1-day | -3.23% | +0.55% |
| YTD | -12.26% | +34.96% |
| 1 year | -11.73% | +43.68% |
| 3 years | +15.70% | -21.35% |
| Market cap | $190.4B | $13.3B |
| P/E | 40.9 | — |
| P/S | 3.95 | 1.15 |
| P/B | 3.73 | 2.05 |
| Revenue growth | +10.00% | +5.30% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 30.1 |
| Net margin % | 9.7 | -6.2 |
| ROE % | 9.2 | -11.1 |
| Debt / equity | 0.61 | 1.45 |
| FCF yield % | 3.5 | 12.3 |
| Dividend yield % | 2.29 | 0.16 |
| Beta | 0.06 | 1.05 |
| RSI (14) | 58.5 | 56.0 |
| Technical rating |